title: In pursuit of P2X3 antagonists: novel therapeutics for chronic pain and afferent sensitization.
abstract: Treating pain by inhibiting ATP activation of P2X3-containing receptors heralds an exciting new approach to pain management, and Afferent's program marks the vanguard in a new class of drugs poised to explore this approach to meet the significant unmet needs in pain management. P2X3 receptor subunits are expressed predominately and selectively in so-called C- and Aδ-fiber primary afferent neurons in most tissues and organ systems, including skin, joints, and hollow organs, suggesting a high degree of specificity to the pain sensing system in the human body. P2X3 antagonists block the activation of these fibers by ATP and stand to offer an alternative approach to the management of pain and discomfort. In addition, P2X3 is expressed pre-synaptically at central terminals of C-fiber afferent neurons, where ATP further sensitizes transmission of painful signals. As a result of the selectivity of the expression of P2X3, there is a lower likelihood of adverse effects in the brain, gastrointestinal, or cardiovascular tissues, effects which remain limiting factors for many existing pain therapeutics. In the periphery, ATP (the factor that triggers P2X3 receptor activation) can be released from various cells as a result of tissue inflammation, injury or stress, as well as visceral organ distension, and stimulate these local nociceptors. The P2X3 receptor rationale has aroused a formidable level of investigation producing many reports that clarify the potential role of ATP as a pain mediator, in chronic sensitized states in particular, and has piqued the interest of pharmaceutical companies. P2X receptor-mediated afferent activation has been implicated in inflammatory, visceral, and neuropathic pain states, as well as in airways hyperreactivity, migraine, itch, and cancer pain. It is well appreciated that oftentimes new mechanisms translate poorly from models into clinical efficacy and effectiveness; however, the breadth of activity seen from P2X3 inhibition in models offers a realistic chance that this novel mechanism to inhibit afferent nerve sensitization may find its place in the sun and bring some merciful relief to the torment of persistent discomfort and pain. The development philosophy at Afferent is to conduct proof of concept patient studies and best identify target patient groups that may benefit from this new intervention.
authors.affiliation: Afferent Pharmaceuticals, 2755 Campus Dr., Suite 100, San Mateo, CA, 94403, USA, AF@AfferentPharma.com.
authors.forename: Anthony P
authors.initials: AP
authors.lastname: Ford
references.citation: J Neurosci. 2007 Aug 1;27(31):8190-201
references.pmid: 17670966
references.citation: Neuroscience. 2001;108(4):673-85
references.pmid: 11738502
references.citation: J Appl Physiol (1985). 2010 Nov;109(5):1416-23
references.pmid: 20798273
references.citation: Expert Opin Ther Pat. 2010 May;20(5):625-46
references.pmid: 20205618
references.citation: Pain. 2005 Oct;117(3):280-291
references.pmid: 16153775
references.citation: Experientia. 1995 Mar 15;51(3):256-9
references.pmid: 7698289
references.citation: Urology. 2007 Apr;69(4 Suppl):24-33
references.pmid: 17462476
references.citation: Acta Physiol (Oxf). 2010 Jun;199(2):93-147
references.pmid: 20345419
references.citation: Osteoarthritis Cartilage. 2008 Nov;16(11):1421-9
references.pmid: 18448363
references.citation: Pain. 2001 Apr;91(3):351-360
references.pmid: 11275393
references.citation: Front Biosci (Schol Ed). 2011 Jun 01;3:1443-56
references.pmid: 21622280
references.citation: Am J Respir Cell Mol Biol. 2000 Jul;23(1):52-61
references.pmid: 10873153
references.citation: J Physiol. 2002 Jun 1;541(Pt 2):591-600
references.pmid: 12042363
references.citation: Br J Pharmacol. 2010 Jul;160(6):1387-98
references.pmid: 20590629
references.citation: J Physiol. 2000 May 1;524 Pt 3:891-902
references.pmid: 10790166
references.citation: Gut. 2004 Mar;53 Suppl 2:ii5-8
references.pmid: 14960550
references.citation: Mol Pain. 2009 Nov 30;5:69
references.pmid: 19948030
references.citation: Mol Neurobiol. 2008 Feb;37(1):83-90
references.pmid: 18459072
references.citation: J Neurosci. 2002 Sep 15;22(18):8139-47
references.pmid: 12223568
references.citation: Neurochem Int. 2008 May;52(6):1068-75
references.pmid: 18187233
references.citation: Respir Physiol Neurobiol. 2009 May 30;167(1):36-44
references.pmid: 19135556
references.citation: Expert Opin Ther Targets. 2003 Aug;7(4):513-22
references.pmid: 12885270
references.citation: J Physiol. 1959 Mar 12;145(3):494-504
references.pmid: 13642316
references.citation: Neuron. 2006 Feb 2;49(3):365-77
references.pmid: 16446141
references.citation: J Biol Chem. 2008 Jul 4;283(27):18743-52
references.pmid: 18460469
references.citation: Osteoarthritis Cartilage. 2003 Nov;11(11):821-30
references.pmid: 14609535
references.citation: Bioorg Med Chem Lett. 2009 Mar 15;19(6):1628-31
references.pmid: 19231180
references.citation: Trends Neurosci. 2009 Mar;32(3):128-41
references.pmid: 19232752
references.citation: Br J Pharmacol. 2001 Jan;132(1):259-69
references.pmid: 11156585
references.citation: Brain. 2011 Apr;134(Pt 4):1116-26
references.pmid: 21378097
references.citation: Am J Physiol Heart Circ Physiol. 2010 May;298(5):H1330-9
references.pmid: 20173045
references.citation: Ann Rheum Dis. 2012 Oct;71(10):1630-5
references.pmid: 22966146
references.citation: Eur J Neurosci. 2010 May;31(9):1629-36
references.pmid: 20525075
references.citation: PLoS One. 2008 Jul 09;3(7):e2599
references.pmid: 18612415
references.citation: Neuron. 2010 Nov 18;68(4):739-49
references.pmid: 21092862
references.citation: Cell Physiol Biochem. 2010;25(2-3):325-36
references.pmid: 20110693
references.citation: Nucleic Acids Res. 2004 Mar 16;32(5):e49
references.pmid: 15026538
references.citation: Expert Opin Ther Targets. 2008 May;12(5):647-61
references.pmid: 18410246
references.citation: Am J Physiol Heart Circ Physiol. 2010 Nov;299(5):H1318-27
references.pmid: 20802135
references.citation: Am J Physiol Heart Circ Physiol. 2011 Sep;301(3):H1070-9
references.pmid: 21642505
references.citation: Pain. 2010 May;149(2):284-295
references.pmid: 20207080
references.citation: Neurosci Lett. 2008 Oct 24;444(2):172-5
references.pmid: 18722504
references.citation: Mol Pain. 2010 Aug 24;6:48
references.pmid: 20735819
references.citation: Nature. 1997 Oct 16;389(6652):749-53
references.pmid: 9338789
references.citation: Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2002 Nov;94(5):622-6
references.pmid: 12424458
references.citation: Ann N Y Acad Sci. 2010 Jun;1198:173-81
references.pmid: 20536932
references.citation: J Neurochem. 2007 Nov;103(4):1408-16
references.pmid: 17725579
references.citation: Auton Neurosci. 2009 Jan 28;145(1-2):71-5
references.pmid: 19064335
references.citation: Am J Physiol Lung Cell Mol Physiol. 2008 Nov;295(5):L858-65
references.pmid: 18689601
references.citation: Curr Pharm Des. 2009;15(15):1717-35
references.pmid: 19442186
references.citation: J Neurosci. 2001 Sep 1;21(17):6522-31
references.pmid: 11517241
references.citation: Chem Senses. 2009 Nov;34(9):789-97
references.pmid: 19833661
references.citation: Int J Oral Maxillofac Surg. 2010 Aug;39(8):815-9
references.pmid: 20418063
references.citation: J Physiol. 2011 Feb 1;589(Pt 3):685-95
references.pmid: 21078590
references.citation: Nat Neurosci. 2009 May;12(5):547-8
references.pmid: 19363489
references.citation: Neuron. 2005 Jan 6;45(1):17-25
references.pmid: 15629699
references.citation: Pain. 2002 Sep;99(1-2):11-9
references.pmid: 12237180
references.citation: Pain. 2008 Nov 15;140(1):23-34
references.pmid: 18715715
references.citation: Neuropharmacology. 2004 Dec;47(7):1093-101
references.pmid: 15555643
references.citation: Br J Pharmacol. 1998 Sep;125(2):341-6
references.pmid: 9786507
references.citation: J Physiol. 2011 Jan 15;589(Pt 2):261-2
references.pmid: 21239741
references.citation: J Comp Neurol. 2005 Apr 4;484(2):133-43
references.pmid: 15736235
references.citation: Am J Respir Crit Care Med. 2010 May 1;181(9):928-34
references.pmid: 20093639
references.citation: Auton Neurosci. 2008 May 30;139(1-2):30-7
references.pmid: 18276198
references.citation: J Rheumatol. 1996 Apr;23(4):665-71
references.pmid: 8730124
references.citation: Brain Res. 2004 Feb 13;998(1):130-5
references.pmid: 14725976
references.citation: Am J Physiol Heart Circ Physiol. 2010 Dec;299(6):H1762-71
references.pmid: 20870803
references.citation: Exp Brain Res. 2002 Dec;147(4):511-9
references.pmid: 12444483
references.citation: J Physiol. 2005 Sep 1;567(Pt 2):621-39
references.pmid: 15961431
references.citation: Acta Histochem. 2007;109(4):330-7
references.pmid: 17462717
references.citation: Br J Pharmacol. 2006 Feb;147 Suppl 2:S132-43
references.pmid: 16465177
references.citation: Curr Opin Investig Drugs. 2008 Jul;9(7):716-25
references.pmid: 18600577
references.citation: J Mol Histol. 2007 Aug;38(4):369-71
references.pmid: 17605080
references.citation: Neuropharmacology. 1997 Sep;36(9):1229-42
references.pmid: 9364478
references.citation: Handb Exp Pharmacol. 2011;(202):485-526
references.pmid: 21290240
references.citation: Biochem J. 1986 Jan 15;233(2):309-19
references.pmid: 3006665
references.citation: Neurosci Lett. 2010 Jul 5;478(2):77-81
references.pmid: 20450958
references.citation: Neurochem Int. 2010 Jul;56(8):984-90
references.pmid: 20406659
references.citation: J Physiol. 2011 Apr 1;589(Pt 7):1847-57
references.pmid: 21300753
references.citation: Neuroscience. 2007 Jan 5;144(1):208-16
references.pmid: 17110047
references.citation: Neurochem Int. 2011 Apr;58(5):564-73
references.pmid: 21272608
references.citation: J Neurophysiol. 2010 Dec;104(6):3113-23
references.pmid: 20861433
references.citation: J Physiol. 2010 Dec 15;588(Pt 24):5033-47
references.pmid: 21041525
references.citation: Histochem Cell Biol. 2006 Jun;125(6):681-92
references.pmid: 16341871
references.citation: Eur J Neurosci. 1998 Nov;10(11):3470-8
references.pmid: 9824460
references.citation: J Neurosci. 2003 Sep 10;23(23):8291-301
references.pmid: 12967991
references.citation: Eur J Pharmacol. 2009 Mar 1;605(1-3):9-14
references.pmid: 19101539
references.citation: Trends Pharmacol Sci. 2001 Apr;22(4):182-8
references.pmid: 11282418
references.citation: Eur Urol. 2004 Aug;46(2):247-53
references.pmid: 15245821
references.citation: Development. 2007 Apr;134(7):1407-17
references.pmid: 17329369
references.citation: Auton Neurosci. 2010 Feb 16;153(1-2):106-15
references.pmid: 19679518
references.citation: J Neurosci. 2010 Mar 24;30(12):4503-7
references.pmid: 20335487
references.citation: Novartis Found Symp. 2006;276:26-48; discussion 48-57, 275-81
references.pmid: 16805422
references.citation: Mol Cell Neurosci. 1998 Nov;12(4-5):256-68
references.pmid: 9828090
references.citation: J Pain. 2007 Jul;8(7):588-97
references.pmid: 17481957
references.citation: J Chin Med Assoc. 2007 Oct;70(10):439-44
references.pmid: 17962144
references.citation: Pain. 2005 Dec 15;119(1-3):38-48
references.pmid: 16298067
references.citation: Pain. 1977 Aug;3(4):367-377
references.pmid: 198725
references.citation: Neurochem Int. 2007 Jan;50(2):345-50
references.pmid: 17067723
references.citation: Br J Pharmacol. 2006 Jul;148(6):845-52
references.pmid: 16770326
references.citation: BJU Int. 2001 Jun;87(9):774-9
references.pmid: 11412212
references.citation: BMC Physiol. 2009 Dec 15;9:24
references.pmid: 20003530
references.citation: J Neurosci. 2001 Aug 1;21(15):5670-7
references.pmid: 11466438
references.citation: Brain Res Bull. 2010 Oct 30;83(5):284-91
references.pmid: 20705122
references.citation: Neuroscience. 2010 Dec 1;171(2):588-98
references.pmid: 20851743
references.citation: Pain. 2009 Jan;141(1-2):127-34
references.pmid: 19081189
references.citation: Nature. 2000 Oct 26;407(6807):1011-5
references.pmid: 11069181
references.citation: Brain Res Bull. 2009 Dec 16;80(6):341-6
references.pmid: 19744545
references.citation: Nature. 1966 Oct 22;212(5060):411-2
references.pmid: 4381910
references.citation: Br J Pharmacol. 1999 Dec;128(7):1497-504
references.pmid: 10602329
references.citation: Br J Pharmacol. 1999 May;127(2):449-56
references.pmid: 10385245
references.citation: Knee. 2011 Jun;18(3):160-4
references.pmid: 20627733
references.citation: Proc Natl Acad Sci U S A. 2002 Dec 24;99(26):17179-84
references.pmid: 12482951
references.citation: Brain Res Bull. 2008 Jan 31;75(1):77-82
references.pmid: 18158099
references.citation: Eur J Pain. 2003;7(2):145-53
references.pmid: 12600796
references.citation: Naunyn Schmiedebergs Arch Pharmacol. 2008 Jun;377(4-6):483-90
references.pmid: 17917716
references.citation: Pain. 2011 Jul;152(7):1502-1510
references.pmid: 21398037
references.citation: Neurosci Lett. 2011 Apr 15;493(3):72-5
references.pmid: 21241772
references.citation: Curr Med Chem. 2007;14(14):1505-23
references.pmid: 17584060
references.citation: Science. 2005 Dec 2;310(5753):1495-9
references.pmid: 16322458
references.citation: Purinergic Signal. 2005 Sep;1(3):205-9
references.pmid: 18404505
references.citation: Mol Pain. 2011 Feb 11;7:14
references.pmid: 21314936
references.citation: Bioorg Med Chem Lett. 2010 Feb 1;20(3):1031-6
references.pmid: 20045645
references.citation: Nat Med. 2010 Nov;16(11):1248-57
references.pmid: 20948530
references.citation: J Rheumatol. 1991 May;18(5):716-20
references.pmid: 1650841
references.citation: Brain. 2000 Jun;123 ( Pt 6):1238-46
references.pmid: 10825361
references.citation: Chest. 2005 Oct;128(4):1905-9
references.pmid: 16236834
references.citation: Nature. 1995 Oct 5;377(6548):428-31
references.pmid: 7566119
references.citation: Brain Res. 2005 May 24;1044(2):197-205
references.pmid: 15885218
references.citation: Prog Neurobiol. 2001 Oct;65(2):107-34
references.pmid: 11403876
references.citation: J Urol. 2004 Jan;171(1):448-52
references.pmid: 14665953
references.citation: J Neurosci. 1997 Jul 15;17(14):5297-304
references.pmid: 9204914
references.citation: Brain Res. 2010 Feb 8;1313:215-21
references.pmid: 19968976
references.citation: Brain. 2010 Sep;133(9):2549-64
references.pmid: 20802203
references.citation: Pain. 1999 Mar;80(1-2):273-82
references.pmid: 10204740
references.citation: Purinergic Signal. 2009 Mar;5(1):63-73
references.pmid: 18568426
references.citation: Invest New Drugs. 2007 Dec;25(6):571-9
references.pmid: 17786387
references.citation: J Physiol. 1996 Jan 1;490 ( Pt 1):265-75
references.pmid: 8745294
references.citation: Purinergic Signal. 2010 Jun;6(2):263-72
references.pmid: 20806017
references.citation: Am J Physiol Regul Integr Comp Physiol. 2005 Mar;288(3):R651-5
references.pmid: 15539614
references.citation: J Pediatr Surg. 2001 Nov;36(11):1679-84
references.pmid: 11685701
references.citation: Burns. 2010 Feb;36(1):127-34
references.pmid: 19726132
references.citation: Neurochem Int. 2004 Dec;45(7):987-93
references.pmid: 15337297
references.citation: Eur J Pharmacol. 2006 Oct 10;547(1-3):160-4
references.pmid: 16935279
references.citation: J Neurophysiol. 2008 Apr;99(4):1581-9
references.pmid: 18234974
references.citation: Neuroscience. 2003;120(3):667-75
references.pmid: 12895508
references.citation: J Comp Neurol. 2011 Jan 1;519(1):49-63
references.pmid: 21120927
references.citation: Neurogastroenterol Motil. 2009 Jun;21(6):665-71, e32
references.pmid: 19220757
references.citation: J Neurosci. 2006 Jun 7;26(23):6163-71
references.pmid: 16763024
references.citation: Neuroscience. 2001;107(2):293-300
references.pmid: 11731103
references.citation: J Anat. 1999 Apr;194 ( Pt 3):335-42
references.pmid: 10386771
references.citation: Eur J Pharmacol. 2010 Jul 25;638(1-3):1-4
references.pmid: 20423711
references.citation: Neurosci Lett. 2008 Aug 15;441(1):110-4
references.pmid: 18597934
references.citation: Drug News Perspect. 2005 Oct;18(8):501-7
references.pmid: 16391720
references.citation: Eur J Pharmacol. 2005 Dec 28;528(1-3):158-61
references.pmid: 16321375
references.citation: Neuroscience. 2007 Apr 25;146(1):403-14
references.pmid: 17367943
references.citation: Proc Natl Acad Sci U S A. 2003 Aug 19;100(17):10043-8
references.pmid: 12909716
references.citation: J Pain. 2006 Sep;7(9):659-70
references.pmid: 16942952
references.citation: Mol Pain. 2010 Sep 22;6:59
references.pmid: 20860800
references.citation: Nature. 1995 Oct 5;377(6548):432-5
references.pmid: 7566120
references.citation: Eur J Pharmacol. 2010 Oct 25;645(1-3):79-85
references.pmid: 20558155
references.citation: Exp Physiol. 2006 Jan;91(1):89-102
references.pmid: 16282366
references.citation: Br J Pharmacol. 2003 Dec;140(8):1381-8
references.pmid: 14623769
references.citation: Bioorg Med Chem Lett. 2009 Mar 15;19(6):1632-5
references.pmid: 19231178
references.citation: Curr Opin Pharmacol. 2011 Jun;11(3):254-64
references.pmid: 21705272
references.citation: Neurosci Lett. 1998 Sep 18;254(1):37-40
references.pmid: 9780086
references.citation: J Cardiovasc Pharmacol. 1996 Jun;27(6):872-5
references.pmid: 8761855
references.citation: J Neurophysiol. 2003 Jun;89(6):3243-52
references.pmid: 12783958
references.citation: Pain. 2002 Jul;98(1-2):59-68
references.pmid: 12098617
references.citation: Arch Oral Biol. 2009 Jan;54(1):63-70
references.pmid: 18945422
references.citation: Nature. 2000 Oct 26;407(6807):1015-7
references.pmid: 11069182
references.citation: J Physiol. 1976 Oct;262(1):131-49
references.pmid: 994034